Martingale Asset Management’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-4,011
Closed -$127K – 827
2022
Q4
$127K Hold
4,011
– – ﹤0.01% 814
2022
Q3
$120K Hold
4,011
– – ﹤0.01% 801
2022
Q2
$123K Buy
4,011
+68
+2% +$6.23K ﹤0.01% 821
2022
Q1
$533K Sell
3,943
-20
-0.5% -$2.11K 0.01% 628
2021
Q4
$517K Buy
3,963
+2,253
+132% +$285K 0.01% 640
2021
Q3
$161K Buy
+1,710
New +$174K ﹤0.01% 832

Other funds holding LONA

Martingale Asset Management's LONA Position: Q1 2023 in Review

Martingale Asset Management sold out of LeonaBio Inc (LONA) in Q1 2023, closing a stake of 4,011 shares — an estimated $127K sold.

Martingale Asset Management first reported a position in LONA in Q3 2021 and held it in 6 quarters. The position peaked at $533K in Q1 2022. 83 funds tracked by Wall St. Rank hold LONA as of Q1 2023.

  • Martingale Asset Management reported no remaining LeonaBio Inc position as of Q1 2023 after selling out during the quarter.
  • Martingale Asset Management sold 4,011 LeonaBio Inc shares in Q1 2023, an estimated $127K.
  • Martingale Asset Management first reported a position in LeonaBio Inc in Q3 2021 and held it in 6 quarters.
  • Martingale Asset Management's LeonaBio Inc position peaked at $533K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2023.

Based on Martingale Asset Management's 13F filing for Q1 2023, filed 12 May 2023.